Metnil, as monotherapy, is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes. Metnil is also indicated for use in combination therapy with an oral hypoglycemic agent or insulin when diet and exercise plus the single agent do not result in adequate glycemic control.
Dosage & Administration:
Metnil should be taken in divided doses with meals. The initial dose is 500 mg three times daily or the mean daily dose is 850 mg in the morning and in the evening (12 hourly), preferably after meals. Max. 2550 mg, i.e., 850 mg three times daily may be given or as directed by the physician.
Normally control of diabetes is obtained within a few days, but some time requires up to two weeks.
Metnil Tablet: Each tablet contains Metformin Hydrochloride
BP 500 mg.